Cytotoxic T cell responses against hepatitis B virus polymerase induced by genetic immunization

Journal of Hepatology

Volumn 33, Issue 6, 2000, Pages 986-991

  Putlitz Jasper, Z ^a   Encke, Jens ^a   Wands, Jack R ^b  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^b Liver Research Center Brown University Medical School   (United States)

Author keywords

Cytotoxic T lymphocytes; ELISA; Hepatitis; Polymerase; Vaccine; Vaccinia

Indexed keywords

HEPATITIS B VACCINE; HEPATITIS B VIRUS POLYMERASE; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS ENZYME; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HEPATITIS B; HEPATITIS B VIRUS; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TARGET CELL; VIRUS NUCLEOCAPSID;

EID: 0033645978     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80133-6     Document Type: Article

References (28)

1. Genetic immunization: A new era in vaccines and immune therapeutics
2. The immunologist's grail: Vaccines that generate cellular immunity
3. DNA-based immunization against hepatitis B virus
4. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine
5. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes
6. Hepatitis B virus immunopathogenesis
7. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis
8. Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe
9. Activation of a heterogeneous hepatitis B (HB) core and e antigen- specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection
10. Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion
11. Recognition of hepatitis B virus envelope proteins by liver-infiltrating T lymphocytes in chronic HBV infection
12. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope
13. Mutational analysis of the hepatitis B virus P gene product: Domain structure and RNase H activity
14. Metallothionein
15. Properties of monoclonal antibodies directed against hepatitis B virus polymerase protein
16. Stringent chemical and thermal regulation of recombinant gene expression by vaccinia virus vectors in mammalian cells
17. Immune responses to plasmid DNA encoding the hepatitis C virus core protein
18. Expression and immune response to hepatitis C virus core DNA-based vaccine constructs
19. Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice
20. Cellular and humoral immune response to hepatitis B virus structural proteins in mice after DNA-based immunization
21. DNA immunization induces antibody and cytotoxic T cell responses to hepatitis B core antigen in H-2b mice
22. Characterization of CD8+ cytotoxic T-lymphocyte responses after genetic immunization with retrovirus vectors expressing different forms of the hepatitis B virus core and e antigens
23. DNA-mediated immunization in mice induces a potent MHC class I-restricted cytotoxic T lymphocyte response to the hepatitis B envelope protein
24. Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein
25. HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen
26. HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis
27. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen
28. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection